Type / Class
Equity / American Depositary Shares, each representing 1 Ordinary Shares
Shares outstanding
100M
Number of holders
23
Total 13F shares, excl. options
11.7M
Shares change
-1.84M
Total reported value, excl. options
$17.8M
Value change
-$2.74M
Number of buys
7
Number of sells
-13
Price
$1.52

Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q2 2025

29 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q2 2025.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11.7M shares of 100M outstanding shares and own 11.69% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (4.72M shares), B Group, Inc. (3.26M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (3.18M shares), MACQUARIE GROUP LTD (227K shares), MORGAN STANLEY (92.8K shares), LPL Financial LLC (85.7K shares), BNP PARIBAS FINANCIAL MARKETS (41.3K shares), MILLENNIUM MANAGEMENT LLC (35.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (34.4K shares), and UBS Group AG (25.6K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.